Drug Recall

 

HPS Pharmacies wish to advise that Pfizer Australia, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall of:

Dimetapp® Cough Cold & Flu Daytime/Nightime Liquid Capsules
Paracetamol, dextromethorphan hydrobromide monohydrate, doxylamine succinate
ARTG 137255

The affected products are blister packets of 24 liquid capsules from the following batches:

Batch

Expiry Date

E6715

December 2017

F1453

December 2017

E8895

May 2018

This recall has been initiated after a complaint regarding incorrect capsule placement in a pack of Dimetapp® Cough Cold & Flu Daytime/Nightime Liquid Caps. The “night” capsules were found to be in the morning section of the blister pack and the “day” capsules in the bedtime section.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all affected products for a refund. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on (02) 9850 3397.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates